Related Experiment Video
Updated: Jun 4, 2026
05:33
Using Modified Synthetic Oligonucleotides to Assay Nucleic Acid-Metabolizing Enzymes
Published on: July 5, 2024
[Development of highly nuclease-resistant chemically-modified oligonucleotides]
1Faculty of Pharmaceutical Sciences, Hokkaido University. matuda@pharm.hokudai.ac.jp
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|February 8, 2011
Summary
Chemical modifications enhance therapeutic oligonucleotide stability and efficacy. Novel aminoalkyl linkers and 4'-thio modifications improve resistance to degradation and boost RNA interference activity for potential oligonucleotide therapeutics.
Area of Science:
- Medicinal Chemistry
- Nucleic Acid Chemistry
- Biotechnology
Context:
- Therapeutic oligodeoxyribonucleotides (ODNs) require chemical modification to prevent degradation by nucleases and evade innate immune responses.
- Existing modifications offer partial protection against specific degradation pathways.
Purpose:
- To develop and evaluate novel chemically modified nucleosides for enhanced stability and therapeutic potential of ODNs and RNA.
- To investigate the impact of specific modifications on nuclease resistance, serum stability, and biological activity.
Summary:
- Developed ODNs with aminoalky linkers (5-N-(6-aminohexyl)carbamoyl-2 eal;-deoxyuridine) showing improved thermal stability and resistance to 3 eal;-exonuclease hydrolysis.
- Synthesized ODNs with 4 eal;-"C"-(aminoethyl)thymidine, demonstrating significant resistance to endonuclease (DNase I) and human serum degradation.
- Created 4 eal;-thioribonuclesides ((S)Ns) and incorporated them into RNA aptamers and small interfering RNAs (siRNAs), achieving higher binding affinity and enhanced RNAi activity.
- Developed oligoribonucleotides ((SM)ONs) with 2 eal;-"O"-methyl-4 eal;-thioribonucleosides, exhibiting exceptional stability in human plasma.
Impact:
- Demonstrated significant improvements in nuclease resistance and serum stability for modified ODNs and RNA, crucial for therapeutic applications.
- Identified specific modification patterns in siRNAs that maximize RNA interference efficacy.
- The developed modified nucleosides and oligonucleotides show great promise for the advancement of oligonucleotide therapeutics.
More Related Videos
Related Concept Videos
01:11Restriction Enzymes
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
02:31Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...